Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing.

Lundby C, Achman-Andersen NJ, Thomsen JJ, Norgaard AM, Robach P.

J Appl Physiol (1985). 2008 Aug;105(2):417-9. doi: 10.1152/japplphysiol.90529.2008. Epub 2008 Jun 26.

2.

Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.

Bornø A, Aachmann-Andersen NJ, Munch-Andersen T, Hulston CJ, Lundby C.

Eur J Appl Physiol. 2010 Jun;109(3):537-43. doi: 10.1007/s00421-010-1370-5. Epub 2010 Feb 2.

PMID:
20127125
3.
4.

Detection of the administration of human erythropoietin (HuEPO) to canines.

Bartlett C, Clancy GJ, Cowan DA, Healy JF.

J Anal Toxicol. 2006 Nov-Dec;30(9):663-9.

5.

Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.

Durussel J, Daskalaki E, Anderson M, Chatterji T, Wondimu DH, Padmanabhan N, Patel RK, McClure JD, Pitsiladis YP.

PLoS One. 2013;8(2):e56151. doi: 10.1371/journal.pone.0056151. Epub 2013 Feb 13.

6.

Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".

Saugy M, Robinson N, Lamon S.

J Appl Physiol (1985). 2008 Dec;105(6):1995-6; author reply 1997-8. No abstract available.

7.

Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations?

Lundby C, Robach P.

Eur J Appl Physiol. 2010 Jan;108(1):197-200. doi: 10.1007/s00421-009-1259-3. Epub 2009 Oct 29.

PMID:
19865825
8.

Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.

Souillard A, Audran M, Bressolle F, Gareau R, Duvallet A, Chanal JL.

Br J Clin Pharmacol. 1996 Sep;42(3):355-64.

9.

Injections of recombinant human erythropoietin increases lactate influx into erythrocytes.

Connes P, Caillaud C, Mercier J, Bouix D, Casties JF.

J Appl Physiol (1985). 2004 Jul;97(1):326-32. Epub 2004 Feb 13.

10.

Detection window of Darbepoetin-alpha following one single subcutaneous injection.

Lamon S, Robinson N, Mangin P, Saugy M.

Clin Chim Acta. 2007 Apr;379(1-2):145-9. Epub 2007 Jan 24.

PMID:
17313941
11.

Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.

Varlet-Marie E, Audran M, Lejeune M, Bonafoux B, Sicart MT, Marti J, Piquemal D, Commes T.

Haematologica. 2004 Aug;89(8):991-7.

12.

Stabilization of human urine doping control samples: a current opinion.

Tsivou M, Georgakopoulos DG, Dimopoulou HA, Koupparis MA, Atta-Politou J, Georgakopoulos CG.

Anal Bioanal Chem. 2011 Aug;401(2):553-61. doi: 10.1007/s00216-011-4887-5. Epub 2011 Apr 16.

PMID:
21499681
13.

The evolving science of detection of 'blood doping'.

Lundby C, Robach P, Saltin B.

Br J Pharmacol. 2012 Mar;165(5):1306-15. doi: 10.1111/j.1476-5381.2011.01822.x. Review.

14.

Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA.

J Appl Physiol (1985). 2008 Aug;105(2):581-7. doi: 10.1152/japplphysiol.90484.2008. Epub 2008 Jun 5.

15.

Second-generation blood tests to detect erythropoietin abuse by athletes.

Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG.

Haematologica. 2003 Mar;88(3):333-44.

16.

Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation.

Morkeberg J, Lundby C, Nissen-Lie G, Nielsen TK, Hemmersbach P, Damsgaard R.

Med Sci Sports Exerc. 2007 Oct;39(10):1742-7.

PMID:
17909401
17.

Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.

Belalcazar V, Gutiérrez Gallego R, Llop E, Segura J, Pascual JA.

Electrophoresis. 2006 Nov;27(22):4387-95.

PMID:
17054082
18.

Stabilization of human urine doping control samples: III. Recombinant human erythropoietin.

Tsivou M, Dimopoulou HA, Leontiou IP, Georgakopoulos DG, Koupparis MA, Atta-Politou J, Georgakopoulos CG.

Clin Chim Acta. 2010 Mar;411(5-6):448-52. doi: 10.1016/j.cca.2009.11.029. Epub 2009 Dec 1.

PMID:
19958754
20.

Detection of EPO injections using a rapid lateral flow isoform test.

Lönnberg M, Lundby C.

Anal Bioanal Chem. 2013 Dec;405(30):9685-91. doi: 10.1007/s00216-013-6997-8. Epub 2013 May 10.

PMID:
23657454
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk